Antimicrobial Resistance to Linezolid
Open Access
- 1 October 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (7) , 1010-1015
- https://doi.org/10.1086/423841
Abstract
Acquired resistance to linezolid, the first approved oxazolidinone, has been selected in laboratory experiments and has been observed in clinical isolates of gram-positive cocci. This resistance has typically been associated with single-nucleotide changes in varying numbers of copies of the genes encoding 23S ribosomal RNA. In the current environment of increasingly prevalent resistance to standard antibiotics, linezolid is an important drug because of its activity against a number of clinically significant gram-positive cocci, including multidrug-resistant staphylococci and enterococci. Although resistance to linezolid remains uncommon, the development of resistance by clinical isolates should prompt increased attention to susceptibility testing for this agent and should be taken into account in consideration of the therapeutic use of this drug.Keywords
This publication has 23 references indexed in Scilit:
- Linezolid: The First Oxazolidinone AntimicrobialAnnals of Internal Medicine, 2003
- Ribosomal and non‐ribosomal resistance to oxazolidinones: species‐specific idiosyncrasy of ribosomal alterationsMolecular Microbiology, 2002
- Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998–2000Diagnostic Microbiology and Infectious Disease, 2002
- Resistance to Linezolid: Characterization of Mutations in rRNA and Comparison of Their Occurrences in Vancomycin-Resistant EnterococciAntimicrobial Agents and Chemotherapy, 2001
- rrndb: the Ribosomal RNA Operon Copy Number DatabaseNucleic Acids Research, 2001
- Oxazolidinone Resistance Mutations in 23S rRNA of Escherichia coli Reveal the Central Region of Domain V as the Primary Site of Drug ActionJournal of Bacteriology, 2000
- Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitorsJournal of Antimicrobial Chemotherapy, 2000
- Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center 1 1Edited by D. E. DraperJournal of Molecular Biology, 1999
- Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitorsRNA, 1999
- Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesisAntimicrobial Agents and Chemotherapy, 1988